A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves' Hyperthyroidism?
作者信息
Abdi Hengameh, Zakavi Seyed Rasoul, Azizi Fereidoun
机构信息
Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
出版信息
Int J Endocrinol Metab. 2020 Oct 31;18(4):e108876. doi: 10.5812/ijem.108876. eCollection 2020 Oct.
Abstract
摘要
相似文献
1
A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves' Hyperthyroidism?
Int J Endocrinol Metab. 2020 Oct 31;18(4):e108876. doi: 10.5812/ijem.108876. eCollection 2020 Oct.
2
[Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Lijec Vjesn. 2010 Nov-Dec;132(11-12):355-60.
3
Management of Graves' hyperthyroidism: present and future.
Expert Rev Endocrinol Metab. 2022 Mar;17(2):153-166. doi: 10.1080/17446651.2022.2052044. Epub 2022 Mar 14.
4
Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
J Endocrinol Invest. 1995 Jun;18(6):415-9. doi: 10.1007/BF03349738.
5
Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.
Eur Thyroid J. 2023 Mar 17;12(2). doi: 10.1530/ETJ-22-0226. Print 2023 Apr 1.
6
[Hyperthyroidism in Graves' disease--antithyroid drug treatment].
Z Arztl Fortbild Qualitatssich. 1999 Apr;93 Suppl 1:41-5.
7
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
Lancet Diabetes Endocrinol. 2019 Apr;7(4):278-287. doi: 10.1016/S2213-8587(19)30059-2. Epub 2019 Feb 28.
8
Non-thionamide antithyroid drug options in Graves' hyperthyroidism.
Expert Rev Endocrinol Metab. 2023 Jan;18(1):67-79. doi: 10.1080/17446651.2023.2167709. Epub 2023 Feb 5.
9
Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated I dose.
Clin Diabetes Endocrinol. 2018 Nov 28;4:20. doi: 10.1186/s40842-018-0071-6. eCollection 2018.
10
Long-term remission following antithyroid drug withdrawal in patients with Graves' hyperthyroidism: parameters with prognostic value.
Endocrine. 2019 Feb;63(2):316-322. doi: 10.1007/s12020-018-1785-z. Epub 2018 Oct 17.
引用本文的文献
1
Characteristics of thyrotoxicosis among thyroid patients and their quality of life in a teaching hospital in Jordan: A cross-sectional study.
Pharm Pract (Granada). 2022 Jan-Mar;20(1):2586. doi: 10.18549/PharmPract.2022.1.2586. Epub 2022 Jan 17.
2
Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.
J Endocrinol Invest. 2022 Jun;45(6):1139-1150. doi: 10.1007/s40618-021-01730-1. Epub 2022 Jan 28.
本文引用的文献
1
Antithyroid Drugs.
Iran J Pharm Res. 2019 Fall;18(Suppl1):1-12. doi: 10.22037/ijpr.2020.112892.14005.
2
Effect of Different 131I Dose Strategies for Treatment of Hyperthyroidism on Graves' Ophthalmopathy.
Clin Nucl Med. 2020 Jul;45(7):514-518. doi: 10.1097/RLU.0000000000003086.
3
Improving treatment outcomes for Graves' disease patients with inactive forms of Graves' orbitopathy through an increased dose of radioiodine therapy.
Nuklearmedizin. 2020 Jun;59(3):260-268. doi: 10.1055/a-1149-8552. Epub 2020 May 13.
4
Toward Ultimate Care for Graves' Hyperthyroidism.
Int J Endocrinol Metab. 2019 Nov 2;18(1):e98255. doi: 10.5812/ijem.98255. eCollection 2020 Jan.
5
Long-Term Treatment of Hyperthyroidism with Antithyroid Drugs: 35 Years of Personal Clinical Experience.
Thyroid. 2020 Oct;30(10):1451-1457. doi: 10.1089/thy.2019.0814. Epub 2020 May 11.
6
Should radioiodine now be first line treatment for Graves' disease?
Thyroid Res. 2020 Mar 9;13:3. doi: 10.1186/s13044-020-00077-8. eCollection 2020.
7
Systemic Thyroid Hormone Status in Treated Graves' Disease.
Int J Endocrinol Metab. 2019 Oct 12;17(4):e95385. doi: 10.5812/ijem.95385. eCollection 2019 Oct.
8
Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
Thyroid. 2020 Mar;30(3):357-364. doi: 10.1089/thy.2019.0132. Epub 2020 Feb 26.
9
Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Cohort Study.
Thyroid. 2020 Feb;30(2):243-250. doi: 10.1089/thy.2019.0205. Epub 2020 Jan 23.
10
Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
Thyroid. 2019 Dec;29(12):1828-1833. doi: 10.1089/thy.2019.0150.
Zotero 插件